WN3-10259-10625
2 vaccinations
3 coded responses
18 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 286 / NC
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- 6C6-28838-36348
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Moderna
-
2022-06-30
Registered in v-safe
-
2022-06-30
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Irritability, Somnolence — Feeling: GoodFree text: Sleepiness and grumpiness 24-48 hours after the vaccine, none sinceMedDRA releases: 2024-11 · check-in free text available
- 2022-07-01
- 2022-07-08
- 2022-07-15
- 2022-07-22
- 2022-07-31
-
2022-08-03
Dose 2 — Moderna
-
2022-08-05
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-08-06
- 2022-08-07
- 2022-08-08
- 2022-08-09
- 2022-08-10
-
2022-08-17
Survey response — day 14, dose 2, under 3MedDRA: Cough, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: GoodFree text: Runny nose and cough, negative Covid testMedDRA releases: 2024-11 · check-in free text available
- 2022-08-24
-
2022-08-31
Survey response — day 28, dose 2, under 3MedDRA: Ear infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Report sent to call center — day 28, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-09-07
- 2022-09-14
- 2022-11-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | No |
| 2 | 2022-08-03 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-31 | Successful 2022-09-01 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Sleepiness and grumpiness 24-48 hours after the vaccine, none since
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Runny nose and cough, negative Covid test
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Irritability | · | · | ✓ |
| SRO | Somnolence | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release